Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review.

Jornal Vascular Brasileiro
Diego ChemelloMarco Aurélio Lumertz Saffi

Abstract

Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus anticoagulant. The unique evolution of the case, as well as the positivity for lupus anticoagulant, raises the possibility of an acquired hypercoagulation syndrome. We highlight the fact that the test recommended as the first line for lupus anticoagulant diagnosis (dilute Russell viper venom time) is the most affected by rivaroxaban, leading to a high prevalence of false-positive results. We also discuss potential diagnoses for the current case and review the current state-of-the-art of use of the novel oral anticoagulation agents in this unusual situation. So far, there are no recommendations to use such agents as first options in cerebral venous sinus thrombosis or in hypercoagulation syndromes.

References

Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Feb 5, 2011·Stroke; a Journal of Cerebral Circulation·Gustavo SaposnikUNKNOWN American Heart Association Stroke Council and the Council on Epidemiology and Prevention
Jul 30, 2014·Stroke; a Journal of Cerebral Circulation·Christina GeisbüschSimon Nagel
Feb 25, 2015·International Journal of Stroke : Official Journal of the International Stroke Society·Marcelo D MendonçaMiguel Viana-Baptista
Nov 15, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Scott C WollerC Gregory Elliott
Dec 19, 2016·Thrombosis Research·Katarzyna MalecAnetta Undas
Jun 29, 2017·Journal of Clinical Pharmacy and Therapeutics·J R Schofield, K Hassell
Aug 24, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J M FerroUNKNOWN European Stroke Organization
Sep 13, 2017·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Scott C WollerMatthew T Rondina
Oct 11, 2017·Journal of the Neurological Sciences·Shishir Keekana RaoWazim Mohamed
Jul 14, 2018·Blood·Vittorio PengoAlessandra Banzato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
Erkan IrizMehmet Emin Ozdoğan
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Agnieszka PadjasJacek Musial
© 2021 Meta ULC. All rights reserved